We have provided evidence that either Cdk4 or Cdk6 knockout triggers DNA damage of cancer cells and retards tumor growth in vivo through activation of STING-dependent type I interferon induction pathway and anti-tumor immune responses. This evidence concerns the gene CDK6 and cancer.